230 related articles for article (PubMed ID: 3696836)
1. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Johnson DM; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
Chin NX; Zhang YX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
Neu HC; Chin NX; Labthavikul P
Antimicrob Agents Chemother; 1984 Aug; 26(2):174-80. PubMed ID: 6333207
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
[TBL] [Abstract][Full Text] [Related]
7. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
Knothe H; Shah PM; Eckardt O
Infection; 1991; 19(5):370-6. PubMed ID: 1800379
[TBL] [Abstract][Full Text] [Related]
8. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
Yu KW; Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Bauernfeind A; Jungwirth R
Infection; 1991; 19(5):353-62. PubMed ID: 1800377
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of cefcanel versus other oral cephalosporins.
Chin NX; Gu JW; Neu HC
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Jones RN; Barry AL
Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
[TBL] [Abstract][Full Text] [Related]
13. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
Neu HC; Chin NX; Jules K; Labthavikul P
J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
Neu HC; Saha G; Chin NX
Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
Chin NX; Gu JW; Neu HC
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity and beta-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin.
Scully BE; Jules K; Neu HC
Antimicrob Agents Chemother; 1983 Jun; 23(6):907-13. PubMed ID: 6311090
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
Knapp CC; Sierra-Madero J; Washington JA
Antimicrob Agents Chemother; 1988 Dec; 32(12):1896-8. PubMed ID: 3245701
[TBL] [Abstract][Full Text] [Related]
18. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
[TBL] [Abstract][Full Text] [Related]
19. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Inoue E; Mitsuhashi S
Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]